Weight Management & Obesity Program (Adult)

Weight Management & Obesity Program (Adult)

  • About
  • Approach
  • Who We Treat
  • Appointments
  • Research
  • Locations
  • Doctors

    • The U-M Health Weight Management Program is a 2-year, highly structured, multi-disciplinary and multi-component lifestyle intervention that helps individuals lose weight, keep it off, and reverse their underlying associated health conditions, or prevents them from developing. We are dedicated to educating, motivating and empowering individuals to make healthy lifestyle choices.

    Rewind logo

    Patients with type 2 diabetes or other health conditions that are associated with overweight or obesity can also benefit from our unique collaboration with Rewind, combining proven science with expert clinical care, coaching and team support. Together, we are focused on helping patients improve health by losing weight and keeping it off.

    Our Approach

    Our approach is scientific, and evidence based. We believe in personalized medicine, not a “one-size-fits-all” approach. Many factors impact losing weight and keeping that weight off. We take an integrated approach to weight management by:

    • Assisting patients in achieving a healthy, sustainable diet
    • Providing guidance in increasing physical activity
    • When appropriate, prescribing medications to help promote further weight loss and maintenance of weight loss

    Our staff of experienced providers are dedicated to the evaluation and treatment of individuals with obesity:

    Physicians:

    • Amy E. Rothberg, M.D., D.ABOM, Professor and Director the Weight Management Program and Rewind
    • Andrew T. Kraftson, M.D., Associate Professor
    • Nevin Ajluni, M.D., Assistant Professor
    • Preethi Gogineni, M.D., Assistant Professor
    • Merve Kutahyalioglu, M.D., Assistant Professor
    • Tom Scott-Craig, M.D., Instructor

    Dieticians:

    • Catherine Nay, M.Ed, R.D., C.S.O.W.M, C.H.E.S.
    • Megan Brown, M.P.H, R.D.
    • Sarah Irving, R.D.
    • Nicole Miller, M.P.H., R.D. (Senior Research Associate)

    Our research is sponsored by the Michigan Nutrition and Obesity Research Center, of which Randy Seeley, Ph.D., Professor of Surgery, is Director.

    Who We Treat

    Patients are accepted and enrolled into program after comprehensive review by the multidisciplinary team.  

    All patients must meet one of the following BMI criteria:

    • A BMI ≥ 30 kg/m2-50 kg/m2
    • If Asian, a BMI ≥ 27 kg/m2-50 kg/m2
    • If BMI is > 50 kg/m2, patient or the referring physician may request a review by the REWIND/WMP physician

    The program has two key components.

    • Diet - Patients are prescribed a very-low calorie diet that includes meal replacements during the first 12 weeks. Typical weight loss ranges between 15-25% from baseline weight.  Following this initial period, patients will be transitioned to a low-calorie diet using everyday foods tailored to their personal preferences. We provide education, counseling, guidance, and behavioral support and use evidence-based strategies to facilitate long-term weight loss.
    • Physical Activity - Patients are required to perform 40 minutes of light to moderate physical activity per day (can be divided into 10-minute intervals) during the first 3 months and are graduated to a greater intensity and duration during the weight maintenance phase. 

    It is the patient’s responsibility to determine if Weight Management Program services are a covered benefit under your health plan

    You must have BCBSM*, Blue Care Network, HAP or Priority Health to participate in this program. Costs for meal replacements that are used as part of the individual weight loss program are the responsibility of the patient and are NOT covered by insurance. Some flexible spending accounts allow you to deduct the costs of meal replacement.

    In addition, patients may be responsible for insurance co-pays for visits and prescription medications. 

    Appointment Information

    Referrals can be sent to:

    Domino’s Farms, Lobby C, Ste 1300
    Attn:  MEND – WM
    24 Frank Lloyd Wright Drive
    Ann Arbor, MI  48106-0451

    Phone: 866-266-5221 or 734-647-5871

    Fax: 734-998-1439

    Research

    As part of regular program evaluation, we offer you the opportunity to participate in our research. The research component is completely voluntary. If you decide not to participate in research, your care will not be affected. 

    Part of the research evaluation will provide us with scientific information on your metabolism, psychology, and other aspects of your biology so that we can provide you with the appropriate tools to lose weight and, more importantly, to maintain a healthier weight. These studies will be performed at no cost to you. 

    • Identification of phenotypic factors that predict success for weight loss and long-term weight maintenance
    • The Impact of intensive dietary intervention on weight and health outcomes
    • Preconception weight loss and molecular changes related to birth outcomes

    You and your physician will decide which study is best suited for you during your assessment visit.

    U-M Health is dedicated to patient care as well as developing new knowledge. We look forward to working with you. If you have questions about the research component, please contact our research associate at 734-232-3587 or [email protected]. 

    Locations
    • Metabolism, Endocrinology & Diabetes Clinic | Domino's Farms 24 Frank Lloyd Wright Dr Ste 1300
      Lobby C
      Ann Arbor, MI 48105-9484       Get Directions

    Doctors

     Search for a U-M Health doctor

    Nevin Nuray Ajluni, MD

    Clinical Assistant Professor

    Endocrinology, Internal Medicine

    Preethi Gogineni, MD

    Preethi Gogineni, MD

    Clinical Assistant Professor

    Endocrinology, Internal Medicine

    Andrew Timothy Kraftson, MD

    Andrew Timothy Kraftson, MD

    Clinical Associate Professor

    Endocrinology, Internal Medicine

    Merve Kutahyalioglu, MD

    Merve Kutahyalioglu, MD

    Clinical Assistant Professor

    Endocrinology, Internal Medicine

    labcoat

    Marsha Novick, MD

    Adjunct Clinical Instructor

    Family Medicine

    Amy Elizabeth Rothberg, MD

    Amy Elizabeth Rothberg, MD

    Clinical Professor

    Endocrinology, Internal Medicine

    Michigan Photo

    Thomas Peter Claire Scott-Craig, MD

    Adjunct Clinical Instructor

    Internal Medicine

    News & Stories
    person holding scale with scrubs on and stethoscope
    Health Lab

    7 things to know about Medicare’s new GLP-1 coverage

    Medicare coverage of GLP-1 drugs for weight loss including Wegovy and Zepbound has begun but has limits.
         A hand holding a scoop of protein powder hovering over a cup of water
    Health Lab

    Supplementing with peptides: Good for extra pep or a needless step?

    Health Lab talks to Jorge Ruas, Ph.D., of the U-M Department of Pharmacology, about peptides, how they work and whether supplementing them lends any benefit.
         donut with brain character looking at plate
    Health Lab

    New study reveals a missing step in a weight control pathway that could be targeted for obesity treatment

    New research led by Liangyou Rui, Ph.D., of the Department of Molecular & Integrative Physiology at the University of Michigan Medical School outlines a missing step in one of these alternative pathways, an important discovery in the fight against obesity.
         plants and pills purple background
    Health Lab

    Gut hormone FGF15 changes how mice respond to weight loss

    University of Michigan researchers found that a gut hormone known as fibroblast growth factor 15, or FGF15, is essential for preserving lean mass during diet-induced weight loss. Their results suggest that effective weight-loss strategies need to be tailored to each patient.
         woman hugging patient in exam room
    Health Lab

    A unique patient case inspiring research

    Mallory Mattison serves as the inspiration behind critical medical research that’s supporting other patients like her with lipodystrophy syndromes
         risk of T1D development progessor non-progressor time
    Health Lab

    New hope for early diabetes detection

    The research offers an actionable monitoring method that may guide the administration of current and emerging therapeutics more effectively than the current diagnostics that only assess disease risk or detect disease after destruction of insulin producing cells.